このアイテムのアクセス数: 113
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
KURNS_PR2021_186.pdf | 4.73 MB | Adobe PDF | 見る/開く |
タイトル: | 7. Neutron Capture Therapy |
発行日: | Jul-2022 |
出版者: | Institute for Integrated Radiation and Nuclear Science, Kyoto University |
誌名: | KURNS Progress Report |
巻: | 2021 |
開始ページ: | 186 |
終了ページ: | 221 |
目次: | CO7-1 Synthesis and evaluation of a novel boron neutron capture therapy agent/ H. Kimura and M. Suzuki (R2134) [186] CO7-2 The evaluation of boron neutron capture therapy (BNCT) to the novel mouse model of pelvic recurrence of colorectal cancer/ J. Arima et al. (R3001) [187] CO7-3 The abscopal effect as the late influence after the head neutron-irradiation of mice/ Y. Kinashi et al. (R3028) [188] CO7-4 A Fundamental Investigation on Correlation Between Important Elements for Activation and Major Elements in Concrete and Cements for Radiation Shielding/ K. Kimura et al. (R3031) [189] CO7-5 Development of Amino Acid Derivatives Containing ¹⁰B-Clusters for BNCT/ A. Niitsu et al. (R3040) [190] CO7-6 Enhancement of the cancer cell-killing effects of boron neutron capture therapy by overexpression of LAT1 in cancer stem cell-like cells/ K. Ohnishi et al. (R3042) [191] CO7-7 Effects of overexpression of LAT1 in cancer stem cell-like cells on suppression of tumor growth by boron neutron capture therapy/ K. Ohnishi et al. (R3043) [192] CO7-8 Preliminary Experiment of Tumour Growth Suppression by Intra-Tumoral Injection of Boron-Polyplex/Polymer for Boron Neutron Capture Therapy to Pancreatic Cancer Model in vivo/ H. Yanagie et al. (R3046) [193] CO7-9 Enhancement of Tumour Growth Suppression by Electroporation with Intra-Tumoural Injection of Gadolinium-Polyplex for Gadolinium-Neutron Capture Therapy to Pancreatic Cancer Model in vivo/ H. Yanagie et al. (R3047) [194] CO7-10 Identification of host immunostimulatory effects induced by boron neutron capture therapy/ T. Watanabe et al. (R3048) [195] CO7-11 Basic research to expand the indication of neutron capture therapy to non-neoplastic diseases/ T. Watanabe et al. (R3050) [196] CO7-12 Mechanism of Glioma Resistance After BNCT Conferred by Glioma Niche/ N. Kondo et al. (R3051) [197] CO7-13 Solbilization of All-Trans-Retinoic Acid as Macrophage Polarizer by β-1, 3-Glucan/ N. Yasukawa et al. (R3055) [198] CO7-14 Carborane bearing pullulan nanogel/boron oxide nanoparticle hybrid for BNCT/ R. Kawasaki et al. (R3058) [199] CO7-15 Optimization of polymeric BPA for non-clinical studies and basic study on its analogues/ T. Nomoto et al. (R3060) [200] CO7-16 Development of Boron-Folic Acid Complex and BNCT Antitumor Effect/ K. Nishimura et al. (R3073) [201] CO7-17 Development of Gadolinium-Boron Complexes for MRI-Guided BNCT/ S. Okada et al. (R3074) [202] CO7-18 Water-soluble dodecaborate-containing pyrazolopyrimidine for BNCT/ Y. Hattori et al. (R3082) [203] CO7-19 Attempts to sensitize tumor cells by exploiting the tumor microenvironment/ Y. Sanada et al. (R3102) [204] CO7-20 Establishment of a method for determining position in alpha autoradiography using CR39/ K. Nakai (R3103) [205] CO7-21 Screening of Boron/Gadolinium Compounds for BNCT of Malignant Brain Tumors, 2021/ M. Takagaki et al. (R3107) [206] CO7-22 The effects of radioactivation of animals on the environment for the BNCT to companion animals./ Y. Wada et al. (R3114) [207] CO7-23 In Vivo Efficacy of BPA-Ionic Liquid as a Novel Compound for BNCT/ M. Shirakawa et al. (R3117) [208] CO7-24 Preliminary study of the anti-tumor effect of BNCT using bubble liposome on the canine hemangiosarcoma model/ M. Yanagawa et al. (R3122) [209] CO7-25 Development of boron-nutritional diagnostics in the plant using a neutron capture reaction/ T. Kinouchi (R3126) [210] CO7-26 An Evaluation of the Response of Tumor Cells to BNCT/ Y. Tong et al. (R3129) [211] CO7-27 Development of ¹⁰BPA-loaded mesoporous silica-based nanoparticles and evaluation in BNCT mouse experiments/ F. Tamanoi et al. (R3150) [212] CO7-28 Conjugation of Phenylboronic Acid Moiety through Multistep Organic Transformations on Nanodiamond Surface for an Anticancer Nanodrug of Boron Neutron Capture Therapy/ M. Nishikawa et al. (R3152) [213] CO7-29 The option of BNCT for oral squamous cell carcinomas/ K. Igawa et al. (R3154) [214] CO7-30 New boron drug development research targeting pancreatic cancer/ H. Michiue et al. (R3161) [215] CO7-31 Basic research on new BNCT strategies for melanoma/ H. Michiue et al. (R3162) [216] CO7-32 Quantitative analysis of the contribution of tumor vascular damage to the antitumor effect of X-ray using BNCR/ K. Ono et al. (R3163) [217] CO7-33 Study on Intracellular Protein Destruction by Boron Neutron Capture Reaction/ H. Kakuta et al. (R3167) [218] CO7-34 Observation of Intracellular Boron Neutron Capture Reaction with a Novel Boron Compound/ H. Kakuta et al. (R3168) [219] CO7-35 Development of immune function targeted boron neutron capture therapy using novel nanoparticles/ T. Watanabe and M. Suzuki (R3171) [220] CO7-36 Basic Experiment of Boron Neutron Capture Therapy(BNCT) for a Rat Model of Malignant Spinal Cord Glioma/ R. Kayama et al. (R3172) [221] |
記述: | In case that corrections are made, an errata will be provided in the following webpage: https://www.rri.kyoto-u.ac.jp/PUB/report/PR/ProgRep2021/ProgRep2021.html |
URI: | http://hdl.handle.net/2433/275850 |
関連リンク: | https://www.rri.kyoto-u.ac.jp/PUB/report/PR/ProgRep2021/ProgRep2021.html |
出現コレクション: | 2021 |

このリポジトリに保管されているアイテムはすべて著作権により保護されています。